Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Using a dexamethasone insert to manage pain and inflammation after vitreoretinal surgery

Official title: Intracanalicular Dexamethasone Insert for Management of Post-operative Pain and Inflammation in Patients Undergoing Vitreoretinal Surgery

Run by The Cleveland Clinic · NCT04371445 · Data updated 2026-11-12

This study tests if a new dexamethasone insert can better manage pain and inflammation after eye surgery compared to regular steroid eye drops for adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedJune 1, 2020
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedJuly 29, 2026
Trial IDNCT04371445 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old scheduled for vitreoretinal surgery, specifically pars plana vitrectomy.

Probably not a fit

Patients with ongoing ocular inflammation, structural lid abnormalities, or those undergoing combined surgical procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a dexamethasone intracanalicular insert compared to traditional topical steroid drops in controlling inflammation and pain following vitreoretinal surgery. Patients aged 18 and older undergoing pars plana vitrectomy for conditions like macular hole or epiretinal membrane removal will be randomly assigned to receive either the insert or topical drops. The study will assess inflammation control at multiple time points post-surgery, providing insights into the reliability of continuous drug delivery versus patient adherence to topical treatments.

Why it matters

Potential benefit: If successful, this approach could lead to improved management of postoperative pain and inflammation, enhancing recovery for patients undergoing vitreoretinal surgery.

How similar studies have gone: While the use of dexamethasone inserts is relatively novel in this specific context, similar approaches in other ophthalmic surgeries have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women \>18 years old
* Planning to undergo vitreoretinal surgery with the procedure type of pars plana vitrectomy for either the indication of macular hole, epiretinal membrane removal, or vitreomacular traction.

Exclusion Criteria:

* Patients undergoing combined cataract or glaucoma procedure, intraocular lens exchange, scleral buckle, and/or implant of a drug delivery system
* History of complications, trauma, adverse events, disease in nasolacrimal region, including dacryocystitis, canaliculitis in either eye
* Structural lid abnormalities such as ectropion or entropion in surgical eye
* Ongoing use of systemic narcotic pain relievers
* Presence of any intraocular inflammation (cells and flare) in the study eye at screening/baseline
* Pain score greater than "0" on the ocular pain assessment in the study eye at screening/baseline
* Active or chronic or recurrent uncontrolled ocular or systemic inflammatory disease, including diabetes
* Other ocular surgeries or procedures during the study period and/or 6 months prior
* Intraoperative complications
* Patients with history of glaucoma (defined as glaucoma requiring 2 or more drops, IOP at baseline greater than 25, or advanced optic nerve cupping). Patients with glaucoma or ocular hypertension controlled with a single drop can be enrolled.
* Patients with a known hypersensitivity to NSAIDs or steroids or any component of the study medication.
* Have used ocular, topical, or systemic NSAIDs within 7 days prior to procedure and during surgery.
* Use of intracameral or subconjunctival NSAIDs or steroids intraoperatively.
* Have used topical, ocular, inhaled or systemic steroids within 14 days prior to procedure
* Are pregnant or nursing/lactating
* Participation as a subject in any clinical study within the 30 days prior to randomization.
* Surgeries using 20 gauge or 23 gauge instruments.

Where it's running

  • Cole Eye Institute, Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Katherine Talcott, M.D. — Cole Eye Institute, Cleveland Clinic
  • Study coordinator: Katherine Talcott, M.D.
  • Email: talcotk@ccf.org
  • Phone: 440 988-4040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.